Core Points - The company ensures the authenticity, accuracy, and completeness of the quarterly report, with all board members and senior management bearing legal responsibility for any misstatements or omissions [2][3][4] Financial Data - The financial statements for the third quarter are unaudited, covering a three-month period from the beginning to the end of the quarter [3][7] - The company has reported non-recurring gains and losses, which are applicable and need to be explained if they are significant [4][6] - The company has not experienced any changes in the number of shareholders or significant changes in the top ten shareholders due to stock lending activities [5][6] Shareholder Information - As of September 30, 2025, the company holds 3,848,095 shares in its repurchase account, representing 1.65% of total shares [5][6] Other Information - The company has not provided any additional important information regarding its operational performance during the reporting period [6][8]
上海昊海生物科技股份有限公司 2025年第三季度报告